Envestnet Asset Management’s ProShares UltraShort Health Care RXD Stock Holding History

Envestnet Asset Management’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,922	Closed	-$336K	–	4065
2023 Q1	$336K	Buy	+12,922	New	+$332K	﹤0.01%	3387
2022 Q4	–	Sell	-9,855	Closed	-$298K	–	4042
2022 Q3	$298K	Sell	9,855 -4,311	-30%	-$116K	﹤0.01%	3355
2022 Q2	$392K	Buy	+14,166	New	+$385K	﹤0.01%	3194
2019 Q1	–	Sell	-2,083	Closed	-$214K	–	3022
2018 Q4	$214K	Buy	+2,083	New	+$200K	﹤0.01%	2654

Other funds holding RXD

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Envestnet Asset Management's RXD Position: Q2 2023 in Review

Envestnet Asset Management sold out of ProShares UltraShort Health Care (RXD) in Q2 2023, closing a stake of 12,922 shares — an estimated $336K sold.

Envestnet Asset Management first reported a position in RXD in Q4 2018 and held it in 4 quarters. The position peaked at $392K in Q2 2022. 2 funds tracked by Wall St. Rank hold RXD as of Q2 2023.

Envestnet Asset Management reported no remaining ProShares UltraShort Health Care position as of Q2 2023 after selling out during the quarter.
Envestnet Asset Management sold 12,922 ProShares UltraShort Health Care shares in Q2 2023, an estimated $336K.
Envestnet Asset Management first reported a position in ProShares UltraShort Health Care in Q4 2018 and held it in 4 quarters.
Envestnet Asset Management's ProShares UltraShort Health Care position peaked at $392K in Q2 2022.
2 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q2 2023.

Based on Envestnet Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.